BPNT2P

Across TCGA pan-cancer cohorts, BPNT2P RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated BPNT2P data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher BPNT2P RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated BPNT2P expression acts as an unfavorable survival marker, although some lineages such as UCS and MESO show a favorable association.

UCS, MESO, and GBM are the cancer types where BPNT2P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	DFS	Tertile	II,III,IV	0.859	0.246	.003	84	view →
MESO	DFS	Tertile	III,IV	0.968	0.350	.031	39	view →
GBM	DFS	Tertile	All	0.080	0.292	.006	27	view →
KIRC	OS	Tertile	II,III,IV	0.284	0.547	.034	18	view →
BLCA	DFS	Tertile	All	0.226	0.601	.026	18	view →
SKCM	OS	Tertile	IV	0.224	0.642	.017	15	view →
KIRP	OS	Tertile	All	0.279	0.716	.011	9	view →
LAML	DFS	Tertile	All	0.560	0.279	.019	8	view →
HNSC	OS	Tertile	IV	0.895	0.689	.043	6	view →
LUAD	DFS	Tertile	III,IV	0.441	0.690	.024	6	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

BPNT2P–UCS (DFS)

Open the UCS breakdown →